Cigna Insurance to Cover Senseonics’ Eversense CGM
By Eliza Skoler and Albert Cai
Cigna health insurance will now cover the 90-day implantable Eversense CGM for people with type 1 or type 2 diabetes who take insulin
Senseonics announced that Cigna insurance will now cover the Eversense, an implantable 90-day continuous glucose monitor (CGM). Cigna will cover Eversense for people with type 1 or type 2 diabetes who take insulin.
Cigna is one of the largest health insurers in the United States, with 17 million members. This means that the Eversense will be covered for 17 million more people, in addition to the 150 million people who already have coverage through other insurance companies (including Aetna, Blue Cross Blue Shield, Humana, and Medicare).
Do you want Eversense but don’t have coverage through a health plan? Learn about the $99 Senseonics Bridge Program.
What is Eversense?
Eversense is an implanted CGM; a pill-sized sensor is inserted in the upper arm for 90 days, and an on-body transmitter sits on top of the skin to send real-time CGM data to a smartphone app (Apple or Android). Other CGMs have on-body sensors that need to be replaced every 7-14 days. Eversense must be calibrated with two fingersticks twice per day.